#sleepscience #circadian #neuroscience beta blockers #geriatrics #gerontology #publichealth #primaryhealthcare #cardiology #neurology #Parkinsons Chronic use of β-blockers confers a time- and dose-dependent increased risk for Parkinson’s disease. http
#geriatrics #neurology #sleepscience #circadian #neuroscience #primaryhealthcare beta blockers #endocrinology #healthliteracy #prevention #gerontology Chronic use of β-blockers confers a time- and dose-dependent increased risk for Parkinson’s disease. h
@NeuroscienceNew #noradrenaline #sleepscience #circadian #neuroscience #aging Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease https://t.co/azQIDxAmcs Prolonged use of β-blockers decreases melatonin s
#hypertension #neurology #primarycare #publichealth #geriatrics Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease https://t.co/azQIDxAmcs Prolonged use of β-blockers decreases melatonin synthesis to 50%
@medical_xpress #primaryhealthcare #neuroscience #geriatrics #agedcare Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease . https://t.co/azQIDxAmcs . Prolonged use of β-blockers decreases melatonin synt
#geriatrics #gerontology #neuroscience #primaryhealthcare #generalpractice #iatrogenic #sleepscience Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease. . https://t.co/azQIDxAmcs
#Parkinson's #dopamine #neuroscience #neurology #agedcare #primaryhealthcare #NCDs #iatrogenic #sleepscience #publichealth #healthliteracy #CVD Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease. . htt
#melatonin #sleepscience #neuroscience Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease. . https://t.co/azQIDxAmcs
@Sunny19801234 高用量でプロプラノロールは有効との報告があるが徐脈など副作用あり前のガイドラインでは本態性振戦を合併した患者に検討程度。2018年版では私が見る限り記載無し。むしろ、慢性的なβ2遮断薬使用がパーキンソン発症リスクとなるとの報告も。 https://t.co/zFbAtyHYSB
#epidemiology #medicine #carers #dementia #generalpractice #primaryhealthcare #agedcare #socialcare #assistedliving #carehomes #menshealth #melatonin Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease. .
#CVD #heartdisease #agedcare #dementia #Parkinson's #patientnavigation Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease. . https://t.co/VJVW8S4hUK
@NeuroscienceNew . Many other medications contribute to neurodegeneration by affecting nocturnal melatonin production, microbiome health, neurotransmitters, liver. Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinso
#sustainability #agedcare #healthcare #healthpromotion #epidemiology #socialcare #Parkinsons #dementia #neuroscience #melatonin #primaryhealthcare Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease. . h
#publichealth #dementia #Alzheimers #Parkinsons #primarycare #generalpractice Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease. . https://t.co/VJVW8S4hUK
#sleep #REMsleep #CVD #agedcare #socialcare #dementia #adenosine #publichealth #primarycare #healthcommunication #healthliteracy #neuroscience Chronic use of beta-blockers confers a time- and dose-dependent increased risk for Parkinson's disease. . https
Koren G, Norton G, Radinsky K, Shalev V. Chronic use of β-blockers and the risk of Parkinson's disease. Clin Drug Investig. 2019; 39: 463-8. https://t.co/I8c1d4RTcH https://t.co/YSgDEMnACc
Chronic Use of β-Blockers and the Risk of Parkinson’s Disease | SpringerLink. https://t.co/lc3CYBPMvn
RT @ScienceofPD: Data collected from an Israeli medical database suggests chronic use of β-blockers confers a time- and dose-dependent incr…
RT @ScienceofPD: Data collected from an Israeli medical database suggests chronic use of β-blockers confers a time- and dose-dependent incr…
An interesting article suggesting that beta-blockers are associated with increased risk for #Parkinsons: https://t.co/EXUGhTh8n8.
Data collected from an Israeli medical database suggests chronic use of β-blockers confers a time- and dose-dependent increased risk for #Parkinsons. Adjusted hazard ratio for Parkinson’s among β-blocker users was 1.51 (95% CI; 1.28–1.77; p < 0.0001).